Did you not find what you were looking for? Try the Advanced Search for more precise search options.
1084 items matching your criteria.
Posted by: Editor1 — on March 28, 2012
NanoScienceWorks.org looks at the dynamic area of nano-semoconductors, and how these tiny devices are fundamentally changing the worlds of computing and communications. We speak with the author of Nano-Semiconductor: Devices and Technology, Dr. Krzysztof Iniewski, who manages R&D developments at Redlen Technologies, Inc., a start-up firm in British Columbia, Canada. His research interests are in VLSI circuits for medical and security applications.
Researchers at University of California at Los Angeles (UCLA) have developed a supercapacitor or electrochemical capacitor (EC) composed of an expanded network of graphene — a one-atom-thick layer of graphitic carbon. The team demonstrated excellent mechanical and electrical properties as well as exceptionally high surface area.
Posted by: Editor1 — on March 04, 2012
A team of MIT researchers has found a way of precisely controlling the width and composition of nanowires as they grow, making it possible to grow complex structures designed for particular applications.
The Cornell NanoScale Science & Technology Facility (CNF) is a national user facility that supports a broad range of nanoscale science and technology projects by providing state-of-the-art resources coupled with expert staff support.
The University of Notre Dame, founded in 1842 by Rev. Edward F. Sorin, C.S.C., of the Congregation of Holy Cross, is an independent, national Catholic university located in Notre Dame, Ind., adjacent to the city of South Bend and approximately 90 miles east of Chicago.
Biomimetic Connections, LLC is a California-based firm established in 2002 to advance the commercialization of bio-inspired and biomimetic IP. Through our suite of biomimetic and bio-inspired IP portfoilios, BioParadigm ACCESS, we serve corporations, bio/material scientists and product design engineers across the engineering spectrum seeking to identify, utilize and commercialize research outcomes derived from 'biological design paradigms' (tm)